Think of Basaglar as a New BRAND of Insulin Glargine...NOT a Generic for Lantus
December 2016
Look for Basaglar (BAY-zuh-glar) to replace Lantus on home med lists...as some insurers drop Lantus from their formularies in 2017.
Basaglar is a new brand of glargine U-100...NOT a Lantus generic.
Whether Basaglar makes its way to your hospital formulary may depend on whether your hospital stocks insulin pens...since Basaglar is only available as a KwikPen device.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote